Advocacy for Standardization and High-Quality Data Collection on Rubella Cases in the WHO European Region

The European Academy of Paediatrics (EAP) and WHO Europe are calling on national paediatric societies to support improved standardization and quality in rubella case reporting and surveillance, as part of a renewed push to eliminate rubella across the WHO European Region.

Rubella remains a serious threat

particularly during pregnancy. While significant progress has been made, inconsistencies in data and underreporting continue to hinder elimination efforts. To address this, the EAP Vaccination Strategic Advisory Group (SAG), led by Dr. Hans Jürgen Dornbusch, On 25 March 2025, EAP and WHO Europe issued a joint letter to national paediatric societies across the region, calling for coordinated action to:

  • Adopt WHO rubella case definitions and surveillance standards
  • Improve accuracy in case classification and laboratory confirmation
  • Raise awareness among healthcare providers
  • Collaborate across borders to strengthen data quality and outbreak response
📘Access WHO Document: Eliminating Measles and Rubella in the WHO European Region

Getting Involved

📬 To support this initiative or request more information, please contact:

 

 

We thank our members and partners for their continued dedication to protecting child health across Europe.

close menu icon

Your Enquiries Are Welcome

We will respond to you by Email

""
 

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

  • BERTHOLD KOLETZKO
Read more